Usefulness of cancer-free survival in estimating the lifetime attributable risk of cancer incidence from radiation exposure
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Seo, Songwon | - |
dc.contributor.author | Lee, Dal Nim | - |
dc.contributor.author | Jin, Young Woo | - |
dc.contributor.author | Lee, Won Jin | - |
dc.contributor.author | Park, Sunhoo | - |
dc.date.accessioned | 2021-09-02T07:22:41Z | - |
dc.date.available | 2021-09-02T07:22:41Z | - |
dc.date.created | 2021-06-16 | - |
dc.date.issued | 2018-09 | - |
dc.identifier.issn | 0952-4746 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/73621 | - |
dc.description.abstract | Risk projection models estimating the lifetime cancer risk from radiation exposure are generally based on exposure dose, age at exposure, attained age, gender and study-population-specific factors such as baseline cancer risks and survival rates. Because such models have mostly been based on the Life Span Study cohort of Japanese atomic bomb survivors, the baseline risks and survival rates in the target population should be considered when applying the cancer risk. The survival function used in the risk projection models that are commonly used in the radiological protection held to estimate the cancer risk from medical or occupational exposure is based on all-cause mortality. Thus, it may not be accurate for estimating the lifetime risk of high-incidence but not life-threatening cancer with a long-term survival rate. Herein, we present the lifetime attributable risk (LAR) estimates of all solid cancers except thyroid cancer, thyroid cancer, and leukemia except chronic lymphocytic leukemia in South Korea for lifetime exposure to 1 mGy per year using the cancer-free survival function, as recently applied in the Fukushima health risk assessment by the World Health Organization. Compared with the estimates of LARs using an overall survival function solely based on all-cause mortality, the LARs of all solid cancers except thyroid cancer, and thyroid cancer evaluated using the cancer-free survival function, decreased by approximately 13% and 1% for men and 9% and 5% for women, respectively. The LAR of leukemia except chronic lymphocytic leukemia barely changed for either gender owing to the small absolute difference between its incidence and mortality. Given that many cancers have a high curative rate and low mortality rate, using a survival function solely based on all-cause mortality may cause an over-estimation of the lifetime risk of cancer incidence. The lifetime fractional risk was robust against the choice of survival function. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | IOP PUBLISHING LTD | - |
dc.subject | THYROID-CANCER | - |
dc.subject | THERAPY | - |
dc.title | Usefulness of cancer-free survival in estimating the lifetime attributable risk of cancer incidence from radiation exposure | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Lee, Won Jin | - |
dc.identifier.doi | 10.1088/1361-6498/aac3f3 | - |
dc.identifier.scopusid | 2-s2.0-85053112680 | - |
dc.identifier.wosid | 000434383000001 | - |
dc.identifier.bibliographicCitation | JOURNAL OF RADIOLOGICAL PROTECTION, v.38, no.3, pp.N17 - N24 | - |
dc.relation.isPartOf | JOURNAL OF RADIOLOGICAL PROTECTION | - |
dc.citation.title | JOURNAL OF RADIOLOGICAL PROTECTION | - |
dc.citation.volume | 38 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | N17 | - |
dc.citation.endPage | N24 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Environmental Sciences & Ecology | - |
dc.relation.journalResearchArea | Public, Environmental & Occupational Health | - |
dc.relation.journalResearchArea | Nuclear Science & Technology | - |
dc.relation.journalResearchArea | Radiology, Nuclear Medicine & Medical Imaging | - |
dc.relation.journalWebOfScienceCategory | Environmental Sciences | - |
dc.relation.journalWebOfScienceCategory | Public, Environmental & Occupational Health | - |
dc.relation.journalWebOfScienceCategory | Nuclear Science & Technology | - |
dc.relation.journalWebOfScienceCategory | Radiology, Nuclear Medicine & Medical Imaging | - |
dc.subject.keywordPlus | THYROID-CANCER | - |
dc.subject.keywordPlus | THERAPY | - |
dc.subject.keywordAuthor | radiation exposure | - |
dc.subject.keywordAuthor | risk projection model | - |
dc.subject.keywordAuthor | cancer | - |
dc.subject.keywordAuthor | cancer-free survival | - |
dc.subject.keywordAuthor | overall survival | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.